vaccine, COVID-19 and CD
Digest more
Plus, what it’s like in Washington D.C. right now.
Updated coronavirus vaccines may not be available until mid-September, and people who are not considered high risk may not be able to access them. Coronavirus infections are climbing again, marking another summer wave as children go back to school.
WHO, AMA, AAP and existing standards recommend that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID-19, should get the vaccine, especially.
In a decision filed this week, U.S. District Judge Brian M. Cogan granted summary judgment to the City of New York, holding that plaintiff Obrian Pastrana failed to establish any violation of his substantive due process rights under the Fourteenth Amendment.
1d
IFLScience on MSNCOVID-19 “Vaccine Alternative” Injection Could Be On Fast-Track To Approval From FDA
Developers Invivyd, Inc. are working on a plan with the FDA that will see their antibody-based product approved if it passes one more clinical trial.
5h
News-Medical.Net on MSNCOVID-19 vaccine successes boosted hesitancy - can trust and equity restore immunization?
Researchers show that countries with higher initial COVID-19 vaccine acceptance also achieved stronger booster uptake, but trust and access remain decisive. The commentary warns that vaccine successes also fueled hesitancy,
The XFG variant was first detected in January in southeast Asia. The earliest U.S. case was in March. So far in MD, case numbers remain low.
For those who don’t fall under the CDC’s new recommendations, experts say coverage would depend entirely on their insurance — with some deciding to fully cover the shot, others requiring a copay and some not covering it at all. Without insurance, a Covid shot can cost up to $140, according to the CDC’s vaccine price list.